Balyasny Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,124,572 shares of ACAD stock, worth $19.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,124,572

Previous 200,000 462.29%

Holding current value

$19.5 Million

Previous $3.25 Million 432.52%

% of portfolio

0.03%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $5.34 Million - $6.75 Million	352,426 Added 45.64%	1,124,572 $17.3 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $11.3 Million - $14.2 Million	772,146 New	772,146 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $5.91 Million - $9.04 Million	284,557 Added 1743.82%	300,875 $9.42 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $340,067 - $546,163	16,318 New	16,318 $340,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $36,607 - $48,028	2,578 New	2,578 $41,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $135,173 - $282,815	10,390 New	10,390 $146,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $1.79 Million - $2.36 Million	-85,687 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $726,855 - $1.17 Million	-43,291 Reduced 33.56%	85,687 $2 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $2.04 Million - $3.19 Million	128,978 New	128,978 $2.14 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $2.79 Million - $3.85 Million	-67,864 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $2.19 Million - $3.42 Million	60,072 Added 770.94%	67,864 $2.8 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $305,913 - $410,872	7,792 New	7,792 $378,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $1.27 Million - $2.16 Million	-78,845 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $16.9 Million - $27 Million	-1,177,231 Reduced 93.72%	78,845 $1.28 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $15.3 Million - $25.6 Million	1,173,483 Added 1420.8%	1,256,076 $26.1 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $4.15 Million - $6.15 Million	-275,365 Reduced 76.93%	82,593 $1.26 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $9.61 Million - $14 Million	357,958	357,958 $10.8 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.81B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Acadia Pharmaceuticals Inc Transaction History